Paul Neyman is a seasoned technology and sales professional with extensive experience in software engineering and global sales leadership. Currently serving as Co-Founder at Areti Health since February 2024, Paul is focused on enhancing clinical trial recruitment through generative AI. In addition, Paul co-owns Bilingva, an interpreting and translation company, since October 2005. Previously, Paul held key roles at Genasys Inc. as Vice President of Global SaaS Sales and at BlackBerry AtHoc as Sales Director, where notable achievements included closing multi-million dollar contracts and driving significant sales growth. Additionally, Paul has a robust engineering background, having contributed to software development in various capacities at leading technology firms such as Mumbo, Inc., Conformiq Inc., and Aleri. Paul holds a Bachelor of Science in Electrical Engineering and Computer Science from the University of California, Berkeley.